An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
HeartBeam to Present at LD Micro Main Event XV Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology firm, will present at the LD Micro Main Event XV Conference in Los Angeles from October 25-27, 2022. CEO Branislav Vajdic, PhD, will lead in-person meetings and a presentation on October 25 at 4:30 pm PT in TRACK 3. The conference highlights HeartBeam's unique 3D-vector ECG technology for heart attack detection. The presentation can be streamed live or viewed later on their investor relations site. More details on registration and the conference can be found online.
Positive
None.
Negative
None.
SANTA CLARA, Calif.--(BUSINESS WIRE)--
HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, will present at the LD Micro Main Event XV Conference being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA on October 25-27, 2022.
HeartBeam Chief Executive Officer and Founder Branislav Vajdic, PhD will conduct in-person one-on-one meetings and deliver the Company’s presentation which can be viewed live and via replay at the webcast link below and will also be available on the HeartBeam investor relations website at ir.heartbeam.com.
LD Micro Main Event XV Conference Date: October 25-27, 2022 Location: Los Angeles, CA Presentation Time: Tuesday, October 25, 2022, at 4:30 pm PT (7:30 pm ET) in TRACK 3
Webcast Registration: https://me22.sequireevents.com/
Format: In-person 1x1’s and Presentations
Speakers: Chief Executive Officer and Founder Branislav Vajdic, PhD
Conference Website: Click here
For more information on the LD Micro Main Event XV Conference, or to schedule a one-on-one meeting with HeartBeam management, please contact your conference representative or you may also email your request to BEAT@mzgroup.us or call Chris Tyson at (949) 491-8235.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. HeartBeam AIMI and AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies. For more information, visit HeartBeam.com.
